Mika Derynck Sells 158,795 Shares of Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Mika Derynck sold 158,795 shares of Bitwise MARA Option Income Strategy ETF stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $60.21, for a total value of $9,561,046.95. Following the sale, the director directly owned 87,373 shares of the company’s stock, valued at approximately $5,260,728.33. This trade represents a 64.51% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bitwise MARA Option Income Strategy ETF Price Performance

Shares of IMRA remained flat at $14.59 during midday trading on Thursday. The stock had a trading volume of 2,981 shares, compared to its average volume of 4,858. The company has a market capitalization of $1.90 million, a P/E ratio of 291.80 and a beta of 2.74. Bitwise MARA Option Income Strategy ETF has a fifty-two week low of $11.99 and a fifty-two week high of $42.32. The firm has a 50 day moving average price of $16.10 and a 200 day moving average price of $15.36.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.